Thompson Tamar bought CPRX

December 8, 2025 · Form 4 insider transaction

Thompson Tamar bought 1,413 shares of Cameron Pharmaceutical Inc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction

Acquired (buy-side)

1,413

Price

N/A

Total value

N/A

InsiderThompson Tamar

RoleDirector

CompanyCameron Pharmaceutical Inc (CPRX)

SecurityCommon Stock, par value $0.001 per share

Transaction codeM — Option exercise

Transaction dateDecember 8, 2025

Filing dateDecember 10, 2025

Shares owned after3,773

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.

View the original Form 4 on SEC EDGAR